ARCHIVES

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

This article is from The Cancer Letter archive.

Vol. 07 No. 49 | December 4, 1981

Download PDF Visit The Full Archive

Related Articles

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

April 12, 1985

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013